21-46430570-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006031.6(PCNT):​c.7977G>C​(p.Gln2659His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.538 in 1,559,684 control chromosomes in the GnomAD database, including 228,653 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar.

Frequency

Genomes: 𝑓 0.49 ( 19204 hom., cov: 33)
Exomes 𝑓: 0.54 ( 209449 hom. )

Consequence

PCNT
NM_006031.6 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -2.90

Publications

47 publications found
Variant links:
Genes affected
PCNT (HGNC:16068): (pericentrin) The protein encoded by this gene binds to calmodulin and is expressed in the centrosome. It is an integral component of the pericentriolar material (PCM). The protein contains a series of coiled-coil domains and a highly conserved PCM targeting motif called the PACT domain near its C-terminus. The protein interacts with the microtubule nucleation component gamma-tubulin and is likely important to normal functioning of the centrosomes, cytoskeleton, and cell-cycle progression. Mutations in this gene cause Seckel syndrome-4 and microcephalic osteodysplastic primordial dwarfism type II. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
PCNT Gene-Disease associations (from GenCC):
  • microcephalic osteodysplastic primordial dwarfism type II
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Moyamoya disease
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.4640954E-6).
BP6
Variant 21-46430570-G-C is Benign according to our data. Variant chr21-46430570-G-C is described in ClinVar as [Benign]. Clinvar id is 159670.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.614 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCNTNM_006031.6 linkc.7977G>C p.Gln2659His missense_variant Exon 37 of 47 ENST00000359568.10 NP_006022.3 O95613-1
PCNTNM_001315529.2 linkc.7623G>C p.Gln2541His missense_variant Exon 37 of 47 NP_001302458.1 O95613-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCNTENST00000359568.10 linkc.7977G>C p.Gln2659His missense_variant Exon 37 of 47 1 NM_006031.6 ENSP00000352572.5 O95613-1

Frequencies

GnomAD3 genomes
AF:
0.491
AC:
74529
AN:
151918
Hom.:
19196
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.343
Gnomad AMI
AF:
0.698
Gnomad AMR
AF:
0.481
Gnomad ASJ
AF:
0.657
Gnomad EAS
AF:
0.632
Gnomad SAS
AF:
0.533
Gnomad FIN
AF:
0.499
Gnomad MID
AF:
0.646
Gnomad NFE
AF:
0.554
Gnomad OTH
AF:
0.533
GnomAD2 exomes
AF:
0.526
AC:
90059
AN:
171372
AF XY:
0.533
show subpopulations
Gnomad AFR exome
AF:
0.329
Gnomad AMR exome
AF:
0.430
Gnomad ASJ exome
AF:
0.650
Gnomad EAS exome
AF:
0.622
Gnomad FIN exome
AF:
0.510
Gnomad NFE exome
AF:
0.558
Gnomad OTH exome
AF:
0.541
GnomAD4 exome
AF:
0.543
AC:
764307
AN:
1407648
Hom.:
209449
Cov.:
58
AF XY:
0.545
AC XY:
379032
AN XY:
695260
show subpopulations
African (AFR)
AF:
0.335
AC:
10771
AN:
32178
American (AMR)
AF:
0.440
AC:
16196
AN:
36826
Ashkenazi Jewish (ASJ)
AF:
0.651
AC:
16469
AN:
25286
East Asian (EAS)
AF:
0.673
AC:
24717
AN:
36732
South Asian (SAS)
AF:
0.535
AC:
42739
AN:
79884
European-Finnish (FIN)
AF:
0.512
AC:
25455
AN:
49728
Middle Eastern (MID)
AF:
0.646
AC:
2786
AN:
4316
European-Non Finnish (NFE)
AF:
0.547
AC:
593582
AN:
1084422
Other (OTH)
AF:
0.542
AC:
31592
AN:
58276
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
22776
45552
68328
91104
113880
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16852
33704
50556
67408
84260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.491
AC:
74577
AN:
152036
Hom.:
19204
Cov.:
33
AF XY:
0.489
AC XY:
36296
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.344
AC:
14270
AN:
41514
American (AMR)
AF:
0.481
AC:
7348
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.657
AC:
2279
AN:
3470
East Asian (EAS)
AF:
0.632
AC:
3252
AN:
5142
South Asian (SAS)
AF:
0.534
AC:
2572
AN:
4818
European-Finnish (FIN)
AF:
0.499
AC:
5273
AN:
10570
Middle Eastern (MID)
AF:
0.622
AC:
183
AN:
294
European-Non Finnish (NFE)
AF:
0.554
AC:
37648
AN:
67936
Other (OTH)
AF:
0.530
AC:
1117
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1873
3746
5620
7493
9366
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
680
1360
2040
2720
3400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.524
Hom.:
6086
Bravo
AF:
0.484
TwinsUK
AF:
0.550
AC:
2041
ALSPAC
AF:
0.544
AC:
2097
ESP6500AA
AF:
0.342
AC:
1499
ESP6500EA
AF:
0.557
AC:
4764
ExAC
AF:
0.453
AC:
51092
Asia WGS
AF:
0.571
AC:
1985
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Microcephalic osteodysplastic primordial dwarfism type II Benign:4
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 31, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 23, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.82
T
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.0020
DANN
Benign
0.89
DEOGEN2
Benign
0.19
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.036
N
LIST_S2
Benign
0.58
T
MetaRNN
Benign
0.0000025
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.0
N
PhyloP100
-2.9
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.083
Sift
Benign
0.093
T
Sift4G
Uncertain
0.032
D
Polyphen
0.031
B
Vest4
0.066
MutPred
0.16
Loss of stability (P = 0.1486);
MPC
0.34
ClinPred
0.021
T
GERP RS
-9.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.032
gMVP
0.078
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2070426; hg19: chr21-47850484; COSMIC: COSV64026155; COSMIC: COSV64026155; API